Oops! Something went wrong, please try again later.
Dr. John Mascarenhas is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS) and a member of the Tisch Cancer Institute. Dr. Mascarenhas is the Director of …
Dr. John Mascarenhas is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS) and a member of the Tisch Cancer Institute. Dr. Mascarenhas is the Director of the Adult Leukemia Program and Leader of Clinical Investigation within the Myeloproliferative Disorders Program at Mount Sinai, under the direction of Dr. Ronald Hoffman. As a clinical investigator in malignant hematology with a focus in translational research involving myeloproliferative neoplasms (MPNs) and evolution to acute myeloid leukemia (AML), he is focused on the evaluation of rationale based novel therapies for patients with MPNs and AML.
Accepted insurances
Insurance information may be incomplete and is subject to change.
1199 SEIU
AETNA - Commercial
AETNA - Medicare
Affinity Medicaid-Medicare-Essential Exchange
AgeWell New York
Amidacare Medicaid
CIGNA Healthcare
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicaid
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - Healthplus FKA Amerigroup Medicaid
How can I update my communication preferences including notification settings?
A:
We alert you when new information is available about your care in MyMountSinai. You can choose how you would like to receive these notifications—by email, text, or...
Save
Share
More
